Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0000899243-21-045070

Director sold 20,176 shares at an average $17.93 ($361,690)

  • Director acquired 20,176 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kiener Peter A · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-15 Exercise or conversion : show line 1 in the form +18,815 $2.86 $53,811 18,815 D
2021-11-15 Sale : show line 2 in the form −18,815 $17.92 $337,165 0 D
2021-11-16 Exercise or conversion : show line 3 in the form +1,361 $2.86 $3,892 1,361 D
2021-11-16 Sale : show line 4 in the form −1,361 $18.02 $24,525 0 D
Open-market sales · 20,176 sh · avg $17.93 · $361,690

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-11-15 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −18,815 107,105 D
2021-11-16 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −1,361 105,744 D
Loading xslF345X03/doc4.xml…